Safe Use of Opioids in Hospitals:Successful Pain Management and ...
Safe Use of Opioids in Hospitals:Successful Pain Management and ...
Safe Use of Opioids in Hospitals:Successful Pain Management and ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Medication <strong>Safe</strong>ty Initiatives:<br />
Risk Reduction Strategies for <strong>Safe</strong> Opioid <strong>Use</strong><br />
June 11, 2013<br />
Presented by:<br />
Miriam Kle<strong>in</strong>, BS, PharmD,<br />
Assistant Director <strong>of</strong> Pharmacy,<br />
Medication <strong>Safe</strong>ty<br />
1
K<strong>in</strong>gs County Hospital Center<br />
• K<strong>in</strong>gs County Hospital Center (KCHC) is a 700-bed, level one trauma center, an acute<br />
care academic <strong>and</strong> public hospital <strong>in</strong> Brooklyn, New York<br />
• More than 200 cl<strong>in</strong>ics provide a wide array <strong>of</strong> ambulatory care services<br />
• One <strong>of</strong> 11 hospitals under New York City Health <strong>and</strong> Hospital Corporations (NYC HHC)<br />
• Mission to provide care to everyone regardless <strong>of</strong> their ability to pay<br />
• Electronic Health Record (eHR)<br />
• Computer Physician Order Entry (CPOE) implemented<br />
• System <strong>in</strong>cludes decision support <strong>and</strong> st<strong>and</strong>ardized order sets<br />
• Guide use <strong>of</strong> formulary drugs <strong>and</strong> protocols<br />
• Electronic Medication Adm<strong>in</strong>istration (eMAR)<br />
• Bar Coded Medication Adm<strong>in</strong>istration (BCMA)<br />
• 90% BCMA Compliance<br />
• Accredited <strong>in</strong> June 2012 by The Jo<strong>in</strong>t Commission<br />
• Cited by surveyors for numerous “Best Practices” <strong>in</strong>clud<strong>in</strong>g High-Alert Medication Program
Turn<strong>in</strong>g a Personal Tragedy Into a<br />
Passion for Avoid<strong>in</strong>g Medication Errors<br />
3
Turn<strong>in</strong>g a Personal Tragedy <strong>in</strong>to a<br />
Passion for Avoid<strong>in</strong>g Medication Errors<br />
“Life-long disability impetus fuels my passions for help<strong>in</strong>g<br />
others to avoid such errors”<br />
Currently, Assistant Director <strong>of</strong> Pharmacy, Medication <strong>Safe</strong>ty at<br />
K<strong>in</strong>gs County Hospital Center<br />
4
“Deep Dive” Medication Chart Review<br />
Adverse Drug Reactions Data<br />
Analysis (Jan-Dec 2011)<br />
• Reported by various ways:<br />
–Adverse Drug Reaction (ADR) Hot-l<strong>in</strong>e<br />
–Behavioral Health Service via email<br />
–Fall Committee Monthly Reports <strong>of</strong> Patients Falls<br />
–Recent: December 2011 Code 99 Patients List<br />
•Review any earlier adverse drug reactions prior to<br />
date/time <strong>of</strong> fall<br />
• Assistant Director <strong>of</strong> Pharmacy,<br />
Medication <strong>Safe</strong>ty:<br />
–Review each reported adverse drug reaction<br />
–Fall Committee Monthly Reports- Review each<br />
patient’s medication pr<strong>of</strong>ile before <strong>and</strong> after<br />
documented date/time <strong>of</strong> fall<br />
• Generate analysis <strong>of</strong> medications<br />
that may cause ADRs<br />
• Drill down to the significant tim<strong>in</strong>g<br />
<strong>and</strong> doses:<br />
–Are the medications classified as high alert<br />
medications?<br />
–Was it a medication error?<br />
Medication Errors Data Analysis<br />
• Evaluate medication errors –<br />
Jan-Dec 2011 data entries<br />
• Report<strong>in</strong>g Process:<br />
– Prescrib<strong>in</strong>g, Dispens<strong>in</strong>g,<br />
Adm<strong>in</strong>istration, Documentation,<br />
Computer<br />
• Medication <strong>Safe</strong>ty<br />
– Track<strong>in</strong>g <strong>and</strong> trend<strong>in</strong>g<br />
• Drill down to the significant<br />
problems <strong>in</strong> medication errors<br />
• Identify the most common issues<br />
– Determ<strong>in</strong>e what is the <strong>in</strong>ternal data<br />
tell<strong>in</strong>g us?<br />
– Risk reduction strategies to reduce<br />
the identified problems <strong>in</strong><br />
medication-use process<br />
Updates: Congestive Heart Failure (CHF) Readmission Task Force <strong>and</strong> Medication Reconciliation
<strong>Safe</strong> Opioid <strong>Use</strong>:<br />
Proactive Risk Assessment<br />
• <strong>Use</strong>d data analysis from <strong>in</strong>ternal KCHC<br />
Adverse Drug Reactions Reports<br />
• Identified area for concern: “trigger drug”<br />
naloxone as reversal agent<br />
• Discovery : HYDROmorphone (High-Alert)<br />
High-Alert Medications as def<strong>in</strong>ed by The Institute for <strong>Safe</strong> Medication Practices (ISMP):<br />
”High-alert medications are drugs that bear a heightened risk <strong>of</strong> caus<strong>in</strong>g significant patient harm<br />
when used <strong>in</strong> error. Although mistakes may or may not be more common with these drugs, the<br />
consequences <strong>of</strong> an error are clearly more devastat<strong>in</strong>g to patients” 1<br />
– Challenges:<br />
• Injectable route prescribed overwhelm<strong>in</strong>g majority <strong>of</strong> time<br />
• High dosages frequently prescribed<br />
6
Medication <strong>Safe</strong>ty Issues:<br />
HYDROmorphone<br />
Multidiscipl<strong>in</strong>ary teamwork - 2012<br />
7
HYDROmorphone:<br />
A High Alert Drug<br />
• Assemble a multi-discipl<strong>in</strong>ary team <strong>in</strong> March 2012<br />
• Share <strong>and</strong> learn meet<strong>in</strong>gs as medication safety <strong>in</strong>itiative<br />
• Focus on patterns <strong>of</strong> HYDROmorphone usage<br />
• Underst<strong>and</strong> potency <strong>of</strong> HYDROmorphone<br />
– 1mg IV HYDROmorphone = 7mg IV morph<strong>in</strong>e<br />
• Review to remove route “IM” (<strong>in</strong>tramuscular)<br />
• Review practices for assessment<br />
– Guidel<strong>in</strong>es for monitor<strong>in</strong>g <strong>and</strong> documentation (vital signs & sedation<br />
scale)<br />
8
HYDROmorphone Issues:<br />
Rais<strong>in</strong>g Awareness<br />
• KCHC Internal Database F<strong>in</strong>d<strong>in</strong>gs 2011<br />
– Adverse Drug Reactions<br />
• Naloxone adm<strong>in</strong>istration as rescue drug<br />
– Medication Errors<br />
• Significant Risk <strong>of</strong> Harm<br />
• Global under-appreciation <strong>of</strong> potency<br />
– Lead to higher doses prescribed<br />
• Significant risk <strong>of</strong> serious adverse drug events<br />
– Respiratory Depression<br />
– Sedation/Drows<strong>in</strong>ess – contributes to falls<br />
• Opioid Tolerant versus Opioid Naive<br />
9
Data Analysis KCHC HYDROmorphone
F<strong>in</strong>d<strong>in</strong>gs-Cl<strong>in</strong>ical Assessments
Risk Reduction Strategies
HYDROmorphone: KCHC Analysis<br />
14
Educational Implementations<br />
• Screen Saver on KCHC desktop<br />
• KCHC Opioid H<strong>and</strong>book for Cl<strong>in</strong>icians<br />
– Pr<strong>in</strong>ted <strong>and</strong> on-l<strong>in</strong>e versions<br />
15
Risk Reduction Strategies: PCA<br />
• CPOE Pre-Built Order for PCA Morph<strong>in</strong>e<br />
• Drug Library for PCA Pump<br />
• Educational Alert<br />
17
Pre-Built CPOE<br />
• Common Order Options<br />
• Analgesics<br />
• ICU Sedation <strong>and</strong> Analgesics Medication<br />
Orders<br />
• Proced. Sed. Analgesia (PSA)<br />
• PRN Pa<strong>in</strong> In-Pt Orders<br />
18
Special Thanks<br />
• Christopher Russo, Director <strong>of</strong> Pharmacy<br />
• Jalil M<strong>in</strong>has, Assistant Director <strong>of</strong> Pharmacy, Informatics<br />
• Chief <strong>of</strong> Pa<strong>in</strong> <strong>Management</strong><br />
• KCHC Multi-Discipl<strong>in</strong>ary Team:Prescribers, Nurses & Pharmacists<br />
• KCHC Leadership <strong>and</strong> IT<br />
• NYC HHC Medication <strong>Safe</strong>ty Council<br />
• GNYHA Cl<strong>in</strong>ical Pharmacy Team-HYDROmorphone Research Articles<br />
19
THE END<br />
20